During the last funding cycle, we demonstrated that specific microbial activities are important for development of CRC, for example the presence of the pathogenic pks gene island, in certain E.coli of the B2 group, is responsible for the synthesis of the secondary metabolite colibactin (Arthur, J.C., et al. (2012), Science 338(6103), 120?123). In addition, we recently observed a correlation between the presence of hydrogen sulfide (H2S)-producing bacteria (HSPB) and the severity of new onset Crohn's disease (CD) in a pediatric population (Mottawea, W., et al, 2016. Nat Commun 7, 1?14.). Our long-term goal is to determine how bacteria-host interaction influences the development of colitis-associated CRC. The objective of the present competitive renewal is to determine how the host and environmental factors regulate the carcinogenic potential of bacteria. The central hypothesis of this project is that host-derived signaling modulates bacterial-generated metabolites to influence carcinogenesis. The rationale for the proposed research is that once we understand the interplay between bacteria and the host, it would be possible to target specific activity and thus development of colitis- associated CRC. We plan to test our central hypothesis and fulfill the overall objective of this application with the following specific aims.
Aim 1. Define inflammatory requirement necessary for bacteria-induced CRC in Il10-/-;Apcmin/+ mice.
Aim 2. Establish temporal mechanism implicated in bacteria-induced CRC in Il10-/-;Apcmin/+ mice.
Aim 3. Determine microbial responses and CRC development following cell type-specific alteration of of MYD88 signaling in Il10-/- mice. The results will potentially not only open new directions of colorectal cancer research (inflammation modulation of microbial functions) but also provide novel targets (tissue-specific microbial sensing and microbial disease-promoting activity) and means (anti-inflammatory and anti-microbial agents) for treating and preventing colorectal cancer.

Public Health Relevance

Numerous evidence links the microbiota to susceptibility to developing colitis and colorectal cancer in preclinical models. However, little is known regarding the interaction between host-derived signaling and carcinogenic potential of the microbiota. This project investigates how specific microbial functions are influenced by host genetics and environmental stressors, such as inflammation, to modulate colorectal cancer development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK073338-11A1
Application #
9616384
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Perrin, Peter J
Project Start
2007-04-01
Project End
2023-04-30
Budget Start
2018-07-01
Budget End
2019-04-30
Support Year
11
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Florida
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Harrison, Christy A; Laubitz, Daniel; Ohland, Christina L et al. (2018) Microbial dysbiosis associated with impaired intestinal Na+/H+ exchange accelerates and exacerbates colitis in ex-germ free mice. Mucosal Immunol 11:1329-1341
Jobin, Christian (2018) Precision medicine using microbiota. Science 359:32-34
Tomkovich, Sarah; Yang, Ye; Winglee, Kathryn et al. (2017) Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis. Cancer Res 77:2620-2632
Yang, Ye; Jobin, Christian (2017) Novel insights into microbiome in colitis and colorectal cancer. Curr Opin Gastroenterol 33:422-427
Pope, Jillian L; Tomkovich, Sarah; Yang, Ye et al. (2017) Microbiota as a mediator of cancer progression and therapy. Transl Res 179:139-154
Mousa, Jarrod J; Yang, Ye; Tomkovich, Sarah et al. (2016) MATE transport of the E. coli-derived genotoxin colibactin. Nat Microbiol 1:15009
Mottawea, Walid; Chiang, Cheng-Kang; Mühlbauer, Marcus et al. (2016) Altered intestinal microbiota-host mitochondria crosstalk in new onset Crohn's disease. Nat Commun 7:13419
Bruner, S D; Jobin, C (2016) Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics. Clin Pharmacol Ther 99:585-7
Tomkovich, Sarah; Jobin, Christian (2016) Microbiota and host immune responses: a love-hate relationship. Immunology 147:1-10
Ohland, Christina L; Jobin, Christian (2015) Microbial activities and intestinal homeostasis: A delicate balance between health and disease. Cell Mol Gastroenterol Hepatol 1:28-40

Showing the most recent 10 out of 62 publications